Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NKGen Biotech, Inc. | Chief Executive Officer | Stock Option (right to buy) | 2M | Dec 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NKGN | NKGen Biotech, Inc. | Dec 6, 2024 | 1 | $0 | 4 | Dec 10, 2024 | Chief Executive Officer |
NKGN | NKGen Biotech, Inc. | Feb 12, 2024 | 1 | $0 | 4 | Feb 14, 2024 | Chief Executive Officer, Director |
NKGN | NKGen Biotech, Inc. | Dec 6, 2023 | 2 | $500 | 4 | Dec 7, 2023 | Chief Executive Officer, Director |
NKGN | NKGen Biotech, Inc. | Dec 4, 2023 | 2 | $850 | 4 | Dec 5, 2023 | Chief Executive Officer, Director |
NKGN | NKGen Biotech, Inc. | Nov 27, 2023 | 2 | $701 | 4 | Nov 28, 2023 | Chief Executive Officer, Director |
NKGN | NKGen Biotech, Inc. | Nov 21, 2023 | 2 | $430 | 4 | Nov 22, 2023 | Chief Executive Officer, Director |
GFOR | NKGen Biotech, Inc. | Sep 28, 2023 | 0 | $0 | 3 | Oct 10, 2023 | Chief Executive Officer, Director |